Format

Send to

Choose Destination
J Thorac Oncol. 2015 Apr;10(4):e16-7. doi: 10.1097/JTO.0000000000000424.

Rapid response to trastuzumab emtansine in a patient with HER2-driven lung cancer.

Author information

1
*Department of Medical Oncology, Cantonal Hospital, Luzern, Switzerland; †Department of Pathology, Cantonal Hospital, Luzern, Switzerland; and ‡Department of Nuclear Medicine, Cantonal Hospital, Luzern, Switzerland.
PMID:
25789838
DOI:
10.1097/JTO.0000000000000424
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center